Beijing Chest Hospital
Beijing Chest Hospital
Explore linked clinical trials.17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Not yet recruiting | Phase 2 | 2026-07-16 | NCT07709585 | |
| To Evaluate the Clinical Efficacy and Safety of Omadacycline in the Treatment of Mycobacterium Abscessus Infection. | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium abscessus Infection, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease | Enrolling by invitation | Not stated | 2026-05-29 | NCT07615309 | |
| Collect Data From Patients Receiving Standardized Anti-tuberculosis Therapy, Collect Monitoring Data, and Evaluate Treatment Efficacy and Potential Adverse Reactions. | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Enrolling by invitation | Not stated | 2026-05-26 | NCT07607288 | |
| Chinese Adaptive Randomised Pneumonia Trial With Respiratory Failure | Severe Pneumonia With Respiratory Failure | Not yet recruiting | Phase 4 | 2026-02-09 | NCT07396701 | |
| Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium abscessus Infection, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease | Enrolling by invitation | Phase 2 | 2026-01-28 | NCT07372781 | |
| A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients | Non Small Cell Lung Cancer NSCLC | Not yet recruiting | Not stated | 2026-01-13 | NCT07338396 | |
| TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease | Mycobacterium Abscessus Pulmonary Disease | Recruiting | Phase 2 | 2025-12-22 | NCT07295938 | |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Not yet recruiting | Phase 3 | 2025-12-08 | NCT07268664 | |
| Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease | Mycobacterium Avium Complex Pulmonary Disease | Recruiting | Phase 4 | 2025-10-09 | NCT07213765 | |
| Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 4 | 2025-09-15 | NCT07174076 | |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Active, not recruiting | Phase 3 | 2025-09-02 | NCT06649721 | |
| Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, rifampicin-resistant tuberculosis, tuberculosis | Active, not recruiting | Phase 3 | 2025-04-01 | NCT06081361 | |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Enrolling by invitation | Phase 1 / Phase 2 | 2025-02-06 | NCT06811025 | |
| Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Enrolling by invitation | Phase 1 / Phase 2 | 2025-02-06 | NCT06811012 | |
| Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease | Enrolling by invitation | Phase 2 | 2025-02-05 | NCT06809413 | |
| Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 2 | 2025-01-08 | NCT06764368 | |
| Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 4 | 2024-05-08 | NCT06403943 |